6-K ·Filed May 14, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This filing is a routine investor relations announcement with no new material information. Monitor the upcoming Phase III MAVERIC trial data readout for the next meaningful catalyst.
Final — all horizons settled through T+60d
CRDL ▲ +7.30% at T+60d
NEUTRAL call +7.30% · α vs SPY +3.71% · entry $1.37 → $1.47
T+1d
-3.65%
call -3.65% · α -2.42%
$1.32
settled 6mo ago
T+5d
-4.38%
call -4.38% · α -3.66%
$1.31
settled 5mo ago
T+20d
-24.82%
call -24.82% · α -23.96%
$1.03
settled 5mo ago
T+60d
+7.30%
call +7.30% · α +3.71%
$1.47
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Cardiol Therapeutics announced participation in a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026. This is a routine investor relations event with no material financial or clinical data disclosed.
Key Facts
- Cardiol Therapeutics will participate in a fireside chat at H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026 at 1:30 p.m. EDT.
- A live webcast will be available on the company's website with a replay for 90 days.
- No financial results, clinical data, or material corporate developments were disclosed in the filing.
Financial Impact
No financial impact — routine investor conference participation with no material disclosures.
Risk Factors
- No new clinical or financial data — stock may trade on sentiment rather than fundamentals.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (9 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000442 |
| Document: cardiol6k.htm | 0001279569-26-000442 |
| Document: 0001279569-26-000442-index-headers.html | 0001279569-26-000442 |
| Document: 0001279569-26-000442-index.html | 0001279569-26-000442 |
| Document: 0001279569-26-000442.txt | 0001279569-26-000442 |
16 reports for CRDL
67% Hit rate @ T+60 Went positive at some point 3 of 6 best @ T+20▲ +30.43%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | SC 13G/A | $1.77 | awaiting T+60 | — | $1.16 (−34.47%) |
Sep 23, 2026 4w ago | 6-K | $1.77 | awaiting T+60 | — | $1.16 (−34.47%) |
Sep 16, 2026 5w ago | 6-K | $1.90 | awaiting T+60 | — | $1.16 (−38.95%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.16 (−41.86%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.16 (−41.86%) |
Sep 9, 2026 6w ago | 6-K | $2.29 | awaiting T+60 | — | $1.16 (−49.24%) |
Aug 5, 2026 11w ago | 6-K | $1.34 | awaiting T+60 | — | $1.16 (−13.44%) |
Jul 14, 2026 15w ago | 6-K | $1.15 $1.32 | ▲ +14.78% | ▲ +11.41% | $1.16 (+0.86%) |
Jul 9, 2026 15w ago | 6-K | $0.9920 $1.41 | ▲ +42.14% | ▲ +40.50% | $1.16 (+16.93%) |
May 26, 2026 22w ago | 6-K | $1.30 $1.96 | ▲ +50.77% | ▲ +48.04% | $1.16 (−10.78%) |
Showing 10 of 16
US Market Status
Market Open — Closes in 43m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers